NioCorp CEO and Executive Chairman Mark Smith Extends Maturity Date of Loans to the Company

PR Newswire

CENTENNIAL, Colo., Dec. 14, 2020 /PRNewswire/ — NioCorp Developments Ltd. (“NioCorp” or the “Company“) (TSX: NB; OTCQX: NIOBF) is pleased to announce agreements with NioCorp CEO and Executive Chairman, Mark A. Smith, to extend the maturity date of its existing $3.5 million non-revolving credit facility with Mr. Smith and a separate $1 million loan from Mr. Smith to December 15, 2021.

Funds drawn on the credit facility will assist the Company in continuing its work to secure project financing for the Elk Creek Project (the “Project”) and move the Project to a construction start once project financing is secured.

The agreements to extend the credit facility and Mr. Smith’s 2015 loan are subject to Toronto Stock Exchange approval and are “related party transactions” under Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions (“MI 61-101”).  Because the value of each of the credit facility and Mr. Smith’s 2015 loan is less than 25% of NioCorp’s market capitalization, the agreements to extend the credit facility and Mr. Smith’s 2015 loan are exempt from the formal valuation and minority shareholder approval requirements of MI 61-101.

NioCorp $NB $NIOBF #Niobium #Scandium #ElkCreek #MarkSmith

For More Information

Contact Jim Sims, VP of External Affairs, NioCorp Developments Ltd., 720-639-4650, [email protected]

https://www.niocorp.com 

About NioCorp

NioCorp is developing a superalloy materials project in Southeast Nebraska that will produce Niobium, Scandium, and Titanium. Niobium is used to produce superalloys as well as High Strength, Low Alloy (“HSLA”) steel, which is a lighter, stronger steel used in automotive, structural, and pipeline applications.  Scandium is a superalloy material that can be combined with Aluminum to make alloys with increased strength and improved corrosion resistance.  Scandium also is a critical component of advanced solid oxide fuel cells.  Titanium is used in various superalloys and is a key component of pigments used in paper, paint and plastics and is also used for aerospace applications, armor and medical implants.

Cautionary Note Regarding Forward-Looking Statements

Certain statements contained in this document may constitute forward-looking statements, including statements regarding the Company’s ability to secure project financing for the Elk Creek Project and move the project to a construction start if and when financing is secured. Readers are cautioned that such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause a change in such assumptions and the actual outcomes and estimates to be materially different from those estimated or anticipated future results, achievements or position expressed or implied by those forward-looking statements. Risks, uncertainties and other factors that could cause NioCorp’s plans or prospects to change include risks related to the Company’s ability to operate as a going concern; risks related to the Company’s requirement of significant additional capital; changes in demand for and price of commodities (such as fuel and electricity) and currencies; changes in economic valuations of the Project, such as Net Present Value calculations, changes or disruptions in the securities markets; legislative, political or economic developments; the need to obtain permits and comply with laws and regulations and other regulatory requirements; the possibility that actual results of work may differ from projections/expectations or may not realize the perceived potential of NioCorp’s projects; risks of accidents, equipment breakdowns and labor disputes or other unanticipated difficulties or interruptions; the possibility of cost overruns or unanticipated expenses in development programs; operating or technical difficulties in connection with exploration, mining or development activities; the speculative nature of mineral exploration and development, including the risks of diminishing quantities of grades of reserves and resources; and the risks involved in the exploration, development and mining business and the risks set forth in the Company’s filings with Canadian securities regulators at www.sedar.com and the SEC at www.sec.gov. NioCorp disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/niocorp-ceo-and-executive-chairman-mark-smith-extends-maturity-date-of-loans-to-the-company-301192435.html

SOURCE NioCorp Developments Ltd.

Innovative Industrial Properties Declares Fourth Quarter 2020 Dividends

Innovative Industrial Properties Declares Fourth Quarter 2020 Dividends

Represents Ninth Increase in Common Stock Dividend since December 2016 IPO

SAN DIEGO–(BUSINESS WIRE)–
Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced today that its board of directors has declared a fourth quarter 2020 dividend of $1.24 per share of common stock, representing an approximately 6% increase over IIP’s third quarter 2020 dividend of $1.17 per share of common stock, and a 24% increase over IIP’s fourth quarter 2019 dividend of $1.00 per share of common stock. The dividend is equivalent to an annualized dividend of $4.96 per common share, and is the ninth dividend increase since IIP completed its initial public offering in December 2016.

Additionally, IIP announced today that its board of directors has declared a regular quarterly dividend of $0.5625 per share of IIP’s 9.00% Series A Cumulative Redeemable Preferred Stock.

The dividends are payable on January 15, 2021 to stockholders of record at the close of business on December 31, 2020.

About Innovative Industrial Properties

Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Innovative Industrial Properties, Inc. has elected to be taxed as a real estate investment trust, commencing with the year ended December 31, 2017. Additional information is available at www.innovativeindustrialproperties.com.

This press release contains statements that IIP believes to be “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than historical facts are forward-looking statements. When used in this press release, words such as we “expect,” “intend,” “plan,” “estimate,” “anticipate,” “believe” or “should” or the negative thereof or similar terminology are generally intended to identify forward-looking statements. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Investors should not place undue reliance upon forward-looking statements. IIP disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

IIP Contact:

Catherine Hastings

Chief Financial Officer, Chief Accounting Officer and Treasurer

Innovative Industrial Properties, Inc.

(858) 997-3332

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Alternative Medicine Health Agriculture Commercial Building & Real Estate Natural Resources Construction & Property REIT

MEDIA:

ZW Data Action Technologies Inc. Announces the Closing of $7.0 Million Registered Direct Offering

BEIJING, Dec. 14, 2020 (GLOBE NEWSWIRE) — ZW Data Action Technologies Inc.(NASDAQ:CNET) (“ZW Data” or the “Company”), an integrated online advertising, precision marketing and data analytics and other value-added services company, today announced the closing on December 14, 2020 of its previously announced registered direct offering of 4,320,989 shares of common stock and warrants to purchase up to 1,728,396 shares of common stock, at a purchase price of $1.62 per share and corresponding warrant. The warrants have a term of three years and are not be exercisable for the first six months from the date of issuance. The warrants have an exercise price of $2.03.

The offering generated aggregate gross proceeds to the Company of approximately $7.0 million, before deducting fees to the placement agent and other estimated offering expenses payable by the Company. The net proceeds from this offering will be used for general working capital purposes.

FT Global Capital, Inc. acted as the exclusive placement agent in connection with the offering.

Loeb & Loeb LLP acted as counsel to the Company and Schiff Hardin LLP acted as counsel to the placement agent in connection with the offering.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities, and these securities cannot be sold in any state in which this offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state. All offers were made only by means of a prospectus, including a prospectus supplement pursuant to the Company’s effective shelf registration statement and base prospectus contained therein. The shelf registration statement (SEC Filing No. 333-228061) relating to the offering was filed with and declared effective by the Securities and Exchange Commission (the “SEC”) on August 3, 2020. A prospectus supplement related to the offering was filed with the SEC on December 11, 2020 and is available at www.sec.gov.

For further details of this transaction, please see the Current Report on Form 8-K filed with the SEC on December 11, 2020 and is available at www.sec.gov.

About ZW Data Action Technologies Inc.

Established in 2003 and headquartered in Beijing, China, ZW Data Action Technologies Inc. (the “Company”) offers online advertising, precision marketing, data analytics and other value-added services for enterprise clients. Leveraging its fully integrated services platform, proprietary database, and cutting-edge algorithms, ZW Data Action Technologies delivers customized, result-driven business solutions for small and medium-sized enterprise clients in China. The Company also develops blockchain and artificial intelligence enabled web/mobile applications and software solutions for general public, enterprise clients, and government agencies. More information about the Company can be found at: http://www.zdat.com/.

Safe Harbor

This release contains certain “forward-looking statements” relating to the business of ZW Data Action Technologies Inc., which can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “estimates” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including business uncertainties relating to government regulation of our industry, market demand, reliance on key personnel, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission. These forward-looking statements are based on ZW Data Action Technologies current expectations and beliefs concerning future developments and their potential effects on the Company. There can be no assurance that future developments affecting ZW Data Action Technologies will be those anticipated by ZW Data Action Technologies. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the Company) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by such forward-looking statements. ZW Data Action Technologies undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

For more information please contact:

Sherry Zheng
Weitian Group LLC
Email: [email protected]
Phone: +1 718-213-7386



Mesoblast Provides Topline Results From Phase 3 Trial of Rexlemestrocel-L for Advanced Chronic Heart Failure

NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced top-line results from the landmark DREAM-HF Phase 3 randomized controlled trial of its allogeneic cell therapy rexlemestrocel-L (REVASCOR®) in 537 patients with advanced chronic heart failure1.

Over a mean 30 months of follow-up, patients with advanced chronic heart failure who received a single endomyocardial treatment with rexlemestrocel-L on top of maximal therapies had 60% reduction in incidence of heart attacks or strokes and 60% reduction in death from cardiac causes when treated at an earlier stage in the progressive disease process. Despite significant reduction in the pre-specified endpoint of cardiac death, there was no reduction in recurrent non-fatal decompensated heart failure events, which was the trial’s primary endpoint. This suggests that rexlemestrocel-L reduces mortality by mechanisms that are distinct from those of existing drugs that reduce hospitalization rates but do not significantly impact cardiac mortality.

“There is an urgent need for new therapies that can reduce the high death rates in heart failure patients by different modes of action from existing drugs which reduce hospitalization rates but have not significantly reduced mortality rates,” said Mesoblast Chief Executive Dr Silviu Itescu. “The reduction in mortality seen with rexlemestrocel-L in advanced chronic heart failure underlines the power of this technology and the commitment of Mesoblast to address diseases in patients with high unmet need which are refractory to existing therapies.”

Key highlights were that a single injection of rexlemestrocel-L, on top of maximal therapy, resulted in the following pre-specified outcomes over a 30-month mean follow-up period:

  • Significant reduction in the incidence of non-fatal ischemic major adverse cardiac events (MACE) due to a heart attack (myocardial infarction, MI) or stroke (cerebrovascular accident, CVA) by 60% relative to controls in the total population of 537 patients (p=0.002); reduction in MACE was seen consistently across both New York Heart Association (NYHA) class II or III populations and irrespective of whether the underlying cause of heart failure was ischemic or non-ischemic
     
  • Significant reduction in death from all cardiac causes (CV death) in the 206 heart failure patients with NYHA class II disease by 60% relative to controls (p=0.037), which was evident in both ischemic and non-ischemic subgroups
     
  • Prevention of NYHA class II patients progressing to CV death rates of NYHA class III patients (p=0.004); in contrast, NYHA class II patients on maximal therapy in the control group progressed to CV death rates of NYHA class III patients after a mean period of 20 months of disease stability
     
  • Significant reduction in the composite of the pre-specified CV death or ischemic MACE outcomes in heart failure patients with NYHA class II disease by 55% relative to controls (p=0.009)

“The trial results show that rexlemestrocel-L significantly reduces cardiovascular mortality when used early in heart failure patients at risk of disease progression, and provides durable protection from heart attacks or strokes in these vulnerable patients,” said the trial’s co-principal investigator Dr Emerson Perin, Director of the Center for Clinical Research, Medical Director of Texas Heart Institute, and Clinical Professor, Baylor College of Medicine. “New therapies have not materially reduced the high death rates from cardiovascular disease which is why these data have the potential to change the treatment paradigm for patients with advanced chronic heart failure.”

Mesoblast Chief Medical Officer Dr Fred Grossman said: “We expect the mortality benefit observed in this seminal Phase 3 trial will support a potential path for approval of rexlemestrocel-L in patients with advanced chronic heart failure. We are planning to meet and discuss potential pathways to approval based on mortality reduction with the United States Food and Drug Administration.”

Conference Call

There will be a webcast today beginning at 9.00am AEDT (Tuesday, December 15); 5.00pm EST
(Monday, December 14, 2020). It can be accessed via https://webcast.boardroom.media/mesoblast-limited/20201214/NaN5fd6e483de11ae0019f60917

The archived webcast will be available on the Investor page of the Company’s website:
www.mesoblast.com

About the DREAM HF Phase 3 Trial

Clinical outcomes were evaluated in 537 advanced heart failure patients (206 with New York Heart Association, NYHA, class II disease and 331 with NYHA class III disease) randomized 1:1 to either a sham procedure or a transendocardial injection by catheter of rexlemestrocel-L (150 million cells). Inclusion criteria enriched the trial for patients with advanced disease by requiring a prior heart failure hospitalization over the past nine months or a N-terminal pro–B-type natriuretic peptide (NT-proBNP) level of at least 1000 pg/ml. All patients were continued on maximal oral agents for heart failure, and were followed for at least twelve months post-procedure.

Baseline characteristics showed that both patient groups with NYHA class II or NYHA class III clinical grades had advanced disease, but those with NYHA class III disease had significantly greater severity (mean NT-proBNP 2568 pg/ml for NYHA class III vs 1842 pg/ml for NYHA class II, p=0.001).

Recurrent non-fatal heart failure MACE, incidence of ischemic MACE due to a heart attack or stroke, and death from cardiovascular causes (CV death), were evaluated over a mean follow-up period of 30 months.

About Mesoblast

Mesoblast is a world leader in developing allogeneic (off-the-shelf) cellular medicines. The Company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of commercial products and late-stage product candidates. Mesoblast has a strong and extensive global intellectual property portfolio with protection extending through to at least 2040 in all major markets. The Company’s proprietary manufacturing processes yield industrial-scale, cryopreserved, off-the-shelf, cellular medicines. These cell therapies, with defined pharmaceutical release criteria, are planned to be readily available to patients worldwide.

Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease and moderate to severe acute respiratory distress syndrome. Mesoblast has completed Phase 3 trials of rexlemestrocel-L for advanced chronic heart failure and chronic low back pain. Two products have been commercialized in Japan and Europe by Mesoblast’s licensees, and the Company has established commercial partnerships in Europe and China for certain Phase 3 assets.

Mesoblast has locations in Australia, the United States and Singapore and is listed on the Australian Securities Exchange (MSB) and on the Nasdaq (MESO). For more information, please see www.mesoblast.com, LinkedIn: Mesoblast Limited and Twitter: @Mesoblast

References

1There were 565 patients randomized of which 537 met the criteria which allowed for treatment to occur on a 1:1 randomization basis between rexlemestrocel-L and sham control

Forward-Looking Statements

This announcement includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. All statements other than statements of historical fact, including our intention to discuss potential pathways to potential approval with the FDA, are forward-looking statements, which are often indicated by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “goal,” “intend,” “likely,” “look forward to,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” and similar expressions and variations thereof. We make such forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Forward-looking statements should not be read as a guarantee of future performance or results, and actual results may differ from the results anticipated in these forward-looking statements, and the differences may be material and adverse. The risks, uncertainties and other factors that may impact our forward-looking statements include, but are not limited to: the timing, progress and results of Mesoblast’s preclinical and clinical studies; Mesoblast’s ability to advance product candidates into, enroll and successfully complete, clinical studies; the timing or likelihood of regulatory filings and approvals; whether the FDA agrees to provide for an accelerated pathway to potential approval; and the pricing and reimbursement of Mesoblast’s product candidates, if approved; Mesoblast’s ability to establish and maintain intellectual property on its product candidates and Mesoblast’s ability to successfully defend these in cases of alleged infringement. You should read this press release together with our risk factors, in our most recently filed reports with the SEC or on our website. Uncertainties and risks that may cause Mesoblast’s actual results, performance or achievements to be materially different from those which may be expressed or implied by such statements, and accordingly, you should not place undue reliance on these forward-looking statements. Unless required by law, we do not undertake any obligations to publicly update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

Release authorized by the Chief Executive.

For more information, please contact:


Corporate Communications / Investors
 
Schond Greenway
T: +1 212 880 2060
E: [email protected]
Paul Hughes
T: +61 3 9639 6036
E: [email protected]
   

Media


Kristen Bothwell
T: +1 917 613 5434
E:[email protected]
 

 



TriplePoint Venture Growth BDC Corp. Announces Extension and Expansion of Its Revolving Credit Facility

TriplePoint Venture Growth BDC Corp. Announces Extension and Expansion of Its Revolving Credit Facility

Facility Increased to $325 Million

MENLO PARK, Calif.–(BUSINESS WIRE)–
TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) (the “Company,” “TPVG,” “we,” “us,” or “our”), the leading financing provider to venture growth stage companies backed by a select group of venture capital firms in the technology and other high growth industries, today announced it has extended and expanded its revolving credit facility (“Credit Facility”). Deutsche Bank AG serves as administrative agent and as a lender, together with existing lenders KeyBank National Association, TIAA, FSB, MUFG Union Bank, N.A., Hitachi Capital America Corporation and NBH Bank, and along with new lender, Customers Bank, under the Credit Facility.

The Credit Facility, as amended, among other things, increases the capacity of the Credit Facility from $300 million to $325 million, extends the revolving period to November 30, 2022 and extends the scheduled maturity date to May 31, 2024. The $25 million increase was made under the accordion feature in the Credit Facility, which allows the Company, under certain circumstances, to increase the size of the Credit Facility to up to $400 million.

“We are pleased to have increased and extended our revolving credit facility and appreciate the continued support of our leading and expanded banking group,” said Christopher Mathieu, Chief Financial Officer of TPVG. “This amended facility further strengthens our liquidity position and prospects for growing the portfolio as we end the year and enter into 2021.”

Borrowings under the Credit Facility are subject to various covenants including the leverage restrictions contained in the Investment Company Act of 1940, as amended, provided that the Company’s asset coverage ratio under the Credit Facility shall not be less than 150%. More information regarding the amendment to the Credit Facility, including a copy thereof, can be found in our Current Report on Form 8-K, filed with the Securities and Exchange Commission (the “SEC”) on December 14, 2020.

ABOUT TRIPLEPOINT VENTURE GROWTH BDC CORP.

The Company was formed to expand the venture growth stage business segment of TriplePoint Capital LLC, the leading global provider of financing across all stages of development to technology, life sciences and other high growth companies backed by a select group of venture capital firms. The Company’s investment objective is to maximize its total return to stockholders primarily in the form of current income and, to a lesser extent, capital appreciation by lending primarily with warrants to venture growth stage companies. The Company is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended.

FORWARD-LOOKING STATEMENTS

Statements included herein may constitute “forward-looking statements,” which relate to future events or our future performance or financial condition. These statements are not guarantees of future events, performance, condition or results and involve a number of risks and uncertainties. Actual results and conditions may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in the Company’s filings with the SEC. You should not place undue reliance on these forward-looking statements. The Company undertakes no duty to update any forward-looking statements made herein, whether as a result of new information, future events or otherwise, except as may be required by law.

The IGB Group

Leon Berman

212-477-8438

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Logo
Logo

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Declares Monthly Distribution

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Declares Monthly Distribution

NEW YORK–(BUSINESS WIRE)–
On December 14, 2020, BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (NYSE: DCF) declared a distribution of $0.050 per share of common stock, payable on January 13, 2021 to shareholders of record at the close of business on December 30, 2020. The ex-dividend date is December 29, 2020. The previous distribution declared in November was $0.050 per share of common stock.

The Fund intends to pay most, but likely not all, of its net income to common shareholders in monthly income dividends. As portfolio and market conditions may change, the distribution rate, the composition of the distribution and the Fund’s policy to declare distributions monthly may be subject to change, including by the Board of Directors.

Important Information

BNY Mellon Investment Adviser, Inc., the investment adviser for the Fund, is part of BNY Mellon Investment Management. BNY Mellon Investment Management is one of the world’s leading investment management organizations and one of the top U.S. wealth managers, with US $2.0 trillion in assets under management as of September 30, 2020. BNY Mellon Investment Management encompasses BNY Mellon’s affiliated investment management firms, wealth management organization and global distribution companies. Through an investor-first approach, BNY Mellon Investment Management brings to clients the best of both worlds: specialist expertise from eight world-class investment firms offering solutions across every major asset class, backed by the strength, stability, and global presence of The Bank of New York Mellon Corporation (NYSE: BK), one of the world’s most trusted investment partners, which has US $38.6 trillion in assets under custody and/or administration as of September 30, 2020.

BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation and may also be used as a generic term to reference the Corporation as a whole or its various subsidiaries generally. Additional information on BNY Mellon Investment Management is available on www.im.bnymellon.com. BNY Mellon Investment Management’s website is intended to allow investors public access to information regarding the Fund and does not, and is not intended to, incorporate the website in this release.

Closed-end funds are traded on the secondary market through one of the stock exchanges. The Fund’s investment returns and principal values will fluctuate so that an investor’s shares may be worth more or less than the original cost. Shares of closed-end funds may trade above (a premium) or below (a discount) the net asset value (NAV) of the fund’s portfolio. There is no assurance that the Fund will achieve its investment objective.

This release is for informational purposes only and should not be considered as investment advice or a recommendation of any particular security.

For Press Inquiries:

BNY Mellon Investment Adviser, Inc.

Benjamin Tanner

(212) 635-8676

For Other Inquiries:

BNY Mellon Securities Corporation

The National Marketing Desk

240 Greenwich Street

New York, New York 10286

1-800-334-6899

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

Century Communities Proudly Sponsors 2020 Denver Christmas for Kids Event

Organized by Denver Active 20-30 Children’s Foundation. Donate today!

PR Newswire

DENVER, Dec. 14, 2020 /PRNewswire/ — Century Communities, Inc., a top 10 national homebuilder, is proud to sponsor the 30th annual Christmas for Kids event, coordinated by the Denver Active 20-30 Children’s Foundation. Made possible through public donations, funds raised for the event provide underprivileged children—nominated by Denver Kids, an organization serving Denver Public Schools students—with a $100 Target® shopping budget to select and purchase Christmas gifts for their families. In addition to making it possible to give their families the gift of Christmas, the program also teaches kids valuable budgeting and organization skills. Each child will also receive a surprise Christmas gift of their own, along with all the fixings for families to enjoy a traditional Christmas meal.

 

LEARN MORE & DONATE:

da2030.org/christmas-for-kids

COVID Event Modifications:
In a typical year, Denver Active 20-30 hosts kids at Target® for an in-person shopping spree and surprise visit from Santa. This year, to practice safety during the pandemic, children will shop virtually, with gifts then wrapped and delivered to their house by members of Denver Active 20-30—who just might show up as festive Christmas characters.

“This year more than ever, we’re especially honored to be a sponsor of this event, helping to support families in need and bring much-needed cheer during a difficult time for so many,” said Alyson Benn, Vice President of Marketing for Century Communities. “Our humble thanks to Denver Active 20-30 and Denver Kids for all their efforts to make this event possible.”

“This year’s Christmas for Kids event is unlike any other,” said Denver Active 20-30 President, David Shirazi. “While the means through which we support and engage the students from Denver Kids has moved virtual, the need by these kids and their families is even greater. We are so grateful to have partners like Century Communities step up to ensure that we can deliver Christmas and the spirit of giving to the deserving children and families of our community.”

ABOUT CENTURY COMMUNITIES
Century Communities, Inc. (NYSE: CCS) is a top 10 national homebuilder. Offering new homes under the Century Communities and Century Complete brands, Century is engaged in all aspects of homebuilding—including the acquisition, entitlement and development of land, along with the construction, innovative marketing and sale of quality homes designed to appeal to a wide range of homebuyers. The Colorado-based company operates in 17 states across the U.S., and offers title, insurance and lending services in select markets through its Parkway Title, IHL Insurance Agency, and Inspire Home Loan subsidiaries. To learn more about Century Communities, please visit www.centurycommunities.com

ABOUT DENVER ACTIVE 20-30 CHILDREN’S FOUNDATION
The Denver Active 20-30 Children’s Foundation (“Denver Active 20-30”) is a non-profit service organization for business leaders between the ages of 20 and 39. Chartered under Active 20-30 International, the Foundation members represent a diversity of professional backgrounds. The mission of the Foundation is to develop philanthropic leaders who mobilize the community to impact the lives of disadvantaged children through annual fund-raising events and projects. Since our inception in 1987, events hosted by Denver Active 20-30 have raised more than $12 million. To learn more, visit https://da2030.org/.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/century-communities-proudly-sponsors-2020-denver-christmas-for-kids-event-301192431.html

SOURCE Century Communities, Inc.

Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable Warrants

PR Newswire

NEW YORK, Dec. 14, 2020 /PRNewswire/ — Eucrates Biomedical Acquisition Corp. (the “Company”), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced that holders of the units sold in the Company’s initial public offering of 10,000,000 units, may elect to separately trade the ordinary shares and redeemable warrants included in the units. Those units not separated will continue to trade on The Nasdaq Capital Market (“Nasdaq”) under the symbol “EUCRU,” and the ordinary shares and redeemable warrants that are separated will trade on the Nasdaq under the symbols “EUCR” and “EUCRW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into ordinary shares and redeemable warrants.

The units were initially offered by the Company in an underwritten offering. Stifel and H.C. Wainwright & Co. acted as joint book-running managers for the offering.

A registration statement relating to the units and the underlying securities was declared effective by the Securities and Exchange Commission (the “SEC”) on October 23, 2020.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on the biomedical and healthcare industry. The Company intends to target North American and European healthcare companies with the potential to drive transformational change through the convergence of biomedicine and data science. “Eucrates” is a portmanteau, formed by combining Euclid (the Father of Geometry) and Hippocrates (the Father of Medicine).

Cautionary Note Concerning Forward-Looking Statements
This press release contains statements that constitute “forward-looking statements.” Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the Securities and Exchange Commission (the “SEC”). Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

* Image in headline from an early copy edition of Euclid’s Elements by the 13th Century scholar and polymath Nasir al-Din al-Tusi (D.1274).

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/eucrates-biomedical-acquisition-corp-announces-the-separate-trading-of-its-ordinary-shares-and-redeemable-warrants-301192430.html

SOURCE Eucrates Biomedical Acquisition Corp.

Advanced Energy Announces Initiation of Quarterly Dividend Program

Advanced Energy Announces Initiation of Quarterly Dividend Program

DENVER–(BUSINESS WIRE)–
Advanced Energy Industries, Inc. (NASDAQ: AEIS), a global leader in highly engineered, precision power conversion, measurement and control solutions, today announced that its Board of Directors has approved the initiation of a cash dividend program under which we intend to pay a regular quarterly dividend of $0.10 per share, starting in the first quarter of 2021. Future dividend payments are subject to approval by the Board of Directors.

“I am pleased to announce the Board’s decision to authorize a regular quarterly cash dividend,” said President & CEO Yuval Wasserman. “We believe the initiation of a quarterly cash dividend program demonstrates confidence in our strategy and our commitment to consistently return capital to shareholders and enhance shareholder value.”

About Advanced Energy

Advanced Energy (Nasdaq: AEIS) is a global leader in the design and manufacturing of highly engineered, precision power conversion, measurement and control solutions for mission-critical applications and processes. AE’s power solutions enable customer innovation in complex applications for a wide range of industries including semiconductor equipment, industrial, manufacturing, telecommunications, data center computing and healthcare. With engineering know-how and responsive service and support around the globe, the company builds collaborative partnerships to meet technology advances, propel growth for its customers and innovate the future of power. Advanced Energy has devoted more than three decades to perfecting power for its global customers and is headquartered in Denver, Colorado, USA. For more information, visit www.advancedenergy.com.

Advanced Energy | Precision. Power. Performance.

Brian Smith

Advanced Energy Industries, Inc.

(970) 407-6555

[email protected]

KEYWORDS: Colorado United States North America

INDUSTRY KEYWORDS: Semiconductor Manufacturing Other Manufacturing Other Technology Technology

MEDIA:

Logo
Logo

EZCORP Reports Fourth Quarter Fiscal Year 2020 Results

EZCORP Reports Fourth Quarter Fiscal Year 2020 Results

AUSTIN, Texas–(BUSINESS WIRE)–
EZCORP, Inc. (NASDAQ: EZPW) today announced results for its fourth quarter and fiscal year ended September 30, 2020.

All amounts in this release are from EZCORP continuing operations and in conformity with U.S. generally accepted accounting principles (“GAAP”) unless otherwise noted. Comparisons shown in this release are to the same period in the prior year unless otherwise noted.

Results for the fourth quarter of fiscal 2020 were impacted by lower pawn service charges related to stimulus payments and ongoing COVID-19 headwinds, as well as charges and non-cash write-downs associated with the Company’s efforts to simplify and streamline its business and other COVID-19 impacts. Given the typical delay between growth in pawn loan originations and pawn service charges, near-term pawn service charge revenue trends will continue to lag the recent stabilization and rebound in new loans made and pawn loans outstanding.

CEO COMMENTARY AND OUTLOOK

Chief Executive Officer Jason Kulas stated, “We continue to make progress on key strategic initiatives. First, we implemented a number of initiatives that will result in a reduction of annual corporate expenses of more than $12 million beginning in fiscal 2021. We have also lowered store-level operating costs by $14 million on an annualized basis. While a majority of those store-level savings will be added back as transaction activity continues to grow, we are realizing significant expense reductions, with an ongoing focus on extracting further operating efficiencies. Second, we continue to strengthen our core pawn business by increasingly leveraging data analytics across geographies to optimize pricing, productivity and returns. Third, recent efforts to rationalize non-core activities have included closing our CASHMAX business in Canada. Finally, we remain focused on innovation to broaden customer engagement across channels, improve the customer experience and capture new business. Our digital pawn servicing platform, Lana, and our other digital efforts have been refocused on achieving these goals.

“At EZCORP, we are focused on optimizing the unique and essential elements of our core pawn business to address customers’ short-term cash needs. We have implemented a culture of continuous operational improvements that will drive operating leverage as we grow and will improve earnings power and shareholder value over time. As we sharpen our focus on continuous improvement in our pawn business, our team is viewing all initiatives through the lens of whether they benefit our core business. We look forward to providing updates on these initiatives in future quarters.”

RESULTS FOR FOURTH QUARTER OF FISCAL 2020

  • Total revenues declined 22% to $166.9 million, and net revenues declined 26% to $89.6 million. These declines were driven by a reduction in revenue from pawn service charges (PSC), which was down 34% to $55.2 million as a result of lower average pawn loans outstanding (PLO) during the quarter.
  • PLO balance at the end of the quarter was $131.3 million, 34% below the prior-year quarter. Pawn loan demand was significantly reduced in the third quarter and into the fourth quarter following economic stimulus actions in the U.S. and constrained traffic in Latin America. Activity levels have started to normalize, with PLO increasing $18.0 million during the quarter as compared to the third quarter of fiscal 2020.
  • Operations expenses were $78.2 million, down $13.3 million, or 15%, $3.9 million of which is due to a reduction in accrued short-term and long-term incentive compensation. Administrative expenses decreased by $11.1 million due to a $17.0 million reduction in accrued short-term and long-term incentive compensation, offset by $4.9 million in increased labor costs.
  • Management implemented strategic initiatives to remove over $12 million in annual corporate expenses beginning in fiscal 2021 and $14 million related to store-level operating costs, a majority of which will be added back as transaction activity continues to increase.
  • Loss before taxes was $28.7 million and diluted loss per share was $0.42, compared to income before taxes of $0.4 million and diluted loss per share of $0.01, respectively, in the prior-year quarter. On an adjusted basis1, loss before taxes was $2.9 million and diluted earnings per share was $0.07, compared to profit before taxes of $10.0 million and diluted earnings per share of $0.13, respectively, in the prior-year quarter.
  • Net inventory of $95.9 million decreased 47%, reflecting annualized inventory turnover of 2.8x. Merchandise sales gross margin of 31% decreased 200 bps, but when excluding a $2.6 million increase in reserves resulting from the impact of COVID-19, merchandise sales gross margin was flat at 33%.
  • Cash and cash equivalents increased $147.0 million to $304.5 million as of the end of the quarter, with most of the increase attributable to the decline in PLO.
  • During the quarter, management began to implement cost savings and refocus initiatives designed to improve bottom line performance and position the Company for sustainable growth focused on the core pawn business. As a result of these initiatives, we recorded the following pre-tax charges in the quarter:

    • $6.4 million in severance benefits related to the elimination of certain management positions;
    • $4.9 million associated with the closure of the CASHMAX business in Canada and related operations;
    • $4.1 million associated with the closure of four stores in U.S. Pawn and three stores in Latin America Pawn; and
    • $5.0 million of other miscellaneous charges.

CONSOLIDATED RESULTS

Three Months Ended September 30

in millions, except per share amounts

 

As Reported

 

Adjusted1

 

2020

 

2019

 

2020

 

2019

 

 

 

 

 

 

 

 

Total Revenues

$

166.9

 

 

$

214.3

 

 

$

170.9

 

$

214.3

Net Revenues

$

89.6

 

 

$

120.9

 

 

$

91.3

 

 

$

121.1

 

(Loss) Income from Continuing Operations, Before Tax

$

(28.7

)

 

$

0.4

 

 

$

2.9

 

 

$

10.0

 

Net (Loss) Income from Continuing Operations

$

(23.3

)

 

$

(0.6

)

 

$

3.8

 

 

$

7.4

 

Diluted Earnings Per Share from Continuing Operations

$

(0.42

)

 

$

(0.01

)

 

$

0.07

 

 

$

0.13

 

Adjusted EBITDA1

$

(16.0

)

 

$

12.1

 

 

$

12.0

 

 

$

19.3

 

  • Total revenues decreased 22% to $166.9 million. PSC was down 34% to $55.2 million due to lower average PLO during the quarter. PLO increased 16% from June 30 to September 30, compared to a 5% sequential gain in the same period of the prior year.
  • Merchandise sales declined 2%, driven primarily by lower inventory levels.
  • Scrap sales declined 72% due to a lack of diamond scrap sales in the quarter as compared to the prior year. Jewelry scrap activity was lower than the prior year in response to lower inventory levels, but the impact of lower volume was lessened by margin improvement to 28%, as compared to 10% in the prior-year quarter. Gross profit on scrap sales decreased 24% to $1.7 million.
  • Net revenues were down 26% to $89.6 million. Consolidated merchandise sales gross profit decreased 7% to $32.3 million, while consolidated merchandise sales gross margin was 31%. When excluding a $2.6 million increase in inventory reserves resulting from the impact of COVID-19, consolidated merchandise sales gross margin was 33%.
  • Consolidated operations expenses decreased 15% primarily due to cost-cutting initiatives at the store level. Total pawn store count increased 1%, consisting of a net 13 stores opened since the end of the prior-year quarter. Administrative expense decreased 78% to $3.1 million, primarily due to a $17.0 million reduction in accrued short-term and long-term incentive compensation, offset by $4.9 million in increased labor costs.

SEGMENT RESULTS

U.S. Pawn

  • Total revenue was down 23%, reflecting the impact of lower average PLO on PSC revenue, which was down 32%.
  • PLO decreased 32% to $106.3 million, but increased $19.5 million, or 23%, since the end of June, compared to a 6% sequential increase during the same period of the prior year.
  • Gross profit on merchandise sales grew $0.7 million, or 2%, reflecting expanded sales margins, partially offset by a 3% reduction in merchandise sales volume, driven primarily by lower inventory levels. Merchandise sales gross margin was 37% (39%, when excluding an increase in inventory reserves of $1.4 million resulting from the impact of COVID-19), at the high end of our targeted range. Annualized inventory turns were 2.5x, a 32% increase over the prior year. Aged general merchandise inventory improved to 4% from 6% in the prior year.
  • Segment contribution decreased $14.6 million to $7.6 million. This decrease was the result of a $20.5 million reduction in PSC, partially offset by a $8.4 million reduction in operating expenses ($2.4 million of which attributable to a reduction in accrued short-term and long-term incentive compensation).

Latin America Pawn

  • Merchandise sales grew 2%, to $27.3 million (11% to $30.0 million on a constant currency basis). Merchandise sales gross margin was 13% (17% when excluding an increase in inventory reserves of $1.2 million resulting from the impact of COVID-19). Aged general merchandise inventory increased to 8% from 6% in the prior year, but declined sequentially from 19% at the end of the prior quarter.
  • PSC decreased 38% to $12.0 million (down 32% to $13.1 million on a constant currency basis) as a result of lower average PLO for the quarter and a lower yield on pawn loans, reflecting our commitment to work with customers by negotiating reduced interest payments on a case-by-case basis.
  • Net revenues decreased 40% to $16.0 million (down 33% to $17.8 million on a constant currency basis) primarily due to lower PSC.
  • Operations expense was tightly managed, down 16% to $16.4 million.
  • Latin America Pawn added seven de novo stores in the quarter. New store openings typically pressure earnings in the short term as they ramp up, but drive higher profitability over time.
  • Segment loss for the quarter was $3.9 million ($4.2 million on a constant currency basis), compared to a contribution of $5.8 million in the prior year quarter, primarily reflecting lower PSC revenues.

FORM 10-K

EZCORP’s Annual Report on Form 10-K for fiscal 2020 has been filed with the Securities and Exchange Commission. The report is available in the Investor Relations section of the Company’s website at http://investors.ezcorp.com. EZCORP shareholders may obtain a paper copy of the report, free of charge, by sending a request to the investor relations contact below.

CONFERENCE CALL

EZCORP will host a conference call on Tuesday, December 15, 2020, at 7:00 am Central Time to discuss fiscal fourth quarter results. Analysts and institutional investors may participate on the conference call by dialing (877) 407-0789, Conference ID: 13713707, or internationally by dialing (201) 689-8562. The conference call will be webcast simultaneously to the public through this link: http://investors.ezcorp.com/. A replay of the conference call will be available online at http://investors.ezcorp.com/ shortly after the end of the call. 

ABOUT EZCORP

Formed in 1989, EZCORP has grown into a leading provider of pawn loans in the United States and Latin America. We also sell merchandise, primarily collateral forfeited from pawn lending operations and used merchandise purchased from customers. We are dedicated to satisfying the short-term cash needs of consumers who are both cash and credit constrained, focusing on an industry-leading customer experience. EZCORP is traded on NASDAQ under the symbol EZPW and is a member of the Russell 2000 Index, S&P 1000 Index and Nasdaq Composite Index.

FORWARD LOOKING STATEMENTS

This announcement contains certain forward-looking statements regarding the company’s strategy, initiatives and expected performance. These statements are based on the Company’s current expectations as to the outcome and timing of future events. All statements, other than statements of historical facts, including all statements regarding the company’s strategy, initiatives and future performance, that address activities or results that the company plans, expects, believes, projects, estimates or anticipates, will, should or may occur in the future, including future financial or operating results, are forward-looking statements. Actual results for future periods may differ materially from those expressed or implied by these forward-looking statements due to a number of uncertainties and other factors, including operating risks, liquidity risks, legislative or regulatory developments, market factors, current or future litigation and risks associated with the COVID-19 pandemic. For a discussion of these and other factors affecting the Company’s business and prospects, see the Company’s annual, quarterly and other reports filed with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time.

1 “Adjusted” basis, which is a non-GAAP measure, excludes certain items. “Constant currency” basis, which is a non-GAAP measure, excludes the impact of foreign currency exchange rate fluctuations. “Free cash flow,” which is a non-GAAP measure, includes certain adjustments to cash flow from operating activities.

For additional information about these calculations, as well as a reconciliation to the most comparable GAAP financial measures, see “Non-GAAP Financial Information” at the end of this release.

EZCORP, Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

 

 

 

 

Three Months Ended

September 30,

 

Fiscal Year Ended

September 30,

 

 

2020

 

2019

 

2020

 

2019

 

 

(Unaudited)

 

 

 

 

 

 

(in thousands, except per share amounts)

Revenues:

 

 

 

 

 

 

 

Merchandise sales

$

105,118

 

 

$

107,189

 

 

$

498,213

 

 

$

453,375

 

Jewelry scrapping sales

6,244

 

 

22,572

 

 

47,953

 

 

60,445

 

Pawn service charges

55,231

 

 

83,068

 

 

272,638

 

 

327,366

 

Other revenues

267

 

 

1,510

 

 

4,007

 

 

6,043

 

Total revenues

166,860

 

 

214,339

 

 

822,811

 

 

847,229

 

Merchandise cost of goods sold

72,770

 

 

72,325

 

 

334,481

 

 

297,508

 

Jewelry scrapping cost of goods sold

4,512

 

 

20,287

 

 

38,041

 

 

52,935

 

Other cost of revenues

(39

)

 

871

 

 

1,054

 

 

2,338

 

Net revenues

89,617

 

 

120,856

 

 

449,235

 

 

494,448

 

Operating expenses:

 

 

 

 

 

 

 

Operations

78,205

 

 

91,525

 

 

341,040

 

 

358,253

 

Administrative

3,100

 

 

14,167

 

 

49,897

 

 

55,990

 

Impairment of goodwill, intangible and other assets

7,606

 

 

 

 

54,666

 

 

 

Depreciation and amortization

7,653

 

 

7,683

 

 

30,827

 

 

28,797

 

Loss on sale or disposal of assets and other

(459

)

 

756

 

 

801

 

 

4,399

 

Other charges

20,388

 

 

 

 

20,388

 

 

 

Total operating expenses

116,493

 

 

114,131

 

 

497,619

 

 

447,439

 

Operating (loss) income

(26,876

)

 

6,725

 

 

(48,384

)

 

47,009

 

Interest expense

5,883

 

 

5,425

 

 

22,472

 

 

32,637

 

Interest income

(761

)

 

(1,449

)

 

(3,173

)

 

(11,086

)

Equity in net loss (income) of unconsolidated affiliates

(3,467

)

 

767

 

 

2,429

 

 

135

 

Impairment of investment in unconsolidated affiliates

 

 

 

 

 

 

19,725

 

Other (income) expense

198

 

 

1,545

 

 

(17

)

 

1,424

 

Income from continuing operations before income taxes

(28,729

)

 

437

 

 

(70,095

)

 

4,174

 

Income tax (benefit) expense

(5,389

)

 

1,029

 

 

(1,632

)

 

2,406

 

(Loss) income from continuing operations, net of tax

(23,340

)

 

(592

)

 

(68,463

)

 

1,768

 

Loss from discontinued operations, net of tax

 

 

(53

)

 

 

 

(457

)

Net (loss) income

(23,340

)

 

(645

)

 

(68,463

)

 

1,311

 

Net loss attributable to noncontrolling interest

 

 

 

 

 

 

(1,230

)

Net (loss) income attributable to EZCORP, Inc.

$

(23,340

)

 

$

(645

)

 

$

(68,463

)

 

$

2,541

 

 

 

 

 

 

 

 

 

Basic (loss) earnings per share attributable to EZCORP, Inc. — continuing operations

$

(0.42

)

 

$

(0.01

)

 

$

(1.24

)

 

$

0.05

 

Diluted (loss) earnings per share attributable to EZCORP, Inc. — continuing operations

$

(0.42

)

 

$

(0.01

)

 

$

(1.24

)

 

$

0.05

 

 

 

 

 

 

 

 

 

Weighted-average basic shares outstanding

55,070

 

 

55,446

 

 

55,313

 

 

55,341

 

Weighted-average diluted shares outstanding

55,070

 

 

55,446

 

 

55,313

 

 

55,984

 

 

EZCORP, Inc.

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

 

 

September 30,

 

2020

 

2019

 

 

 

 

Assets:

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

304,542

 

 

$

157,567

 

Restricted cash

8,011

 

 

4,875

 

Pawn loans

131,323

 

 

199,058

 

Pawn service charges receivable, net

20,580

 

 

31,802

 

Inventory, net

95,891

 

 

179,355

 

Notes receivable, net

 

 

7,182

 

Prepaid expenses and other current assets

32,903

 

 

25,921

 

Total current assets

593,250

 

 

605,760

 

Investments in unconsolidated affiliates

32,458

 

 

34,516

 

Property and equipment, net

56,986

 

 

67,357

 

Lease right-of-use asset

183,809

 

 

 

Goodwill

257,582

 

 

300,527

 

Intangible assets, net

58,638

 

 

68,044

 

Notes receivable, net

1,148

 

 

1,117

 

Deferred tax asset, net

8,931

 

 

1,998

 

Other assets

4,221

 

 

4,383

 

Total assets

$

1,197,023

 

 

$

1,083,702

 

 

 

 

 

Liabilities and equity:

 

 

 

Current liabilities:

 

 

 

Current maturities of long-term debt, net

$

213

 

 

$

214

 

Accounts payable, accrued expenses and other current liabilities

71,504

 

 

77,957

 

Customer layaway deposits

11,008

 

 

12,915

 

Lease liability

49,742

 

 

 

Total current liabilities

132,467

 

 

91,086

 

Long-term debt, net

251,016

 

 

238,380

 

Deferred tax liability, net

524

 

 

1,985

 

Lease liability

153,040

 

 

 

Other long-term liabilities

10,849

 

 

7,302

 

Total liabilities

547,896

 

 

338,753

 

Commitments and contingencies

 

 

 

Stockholders’ equity:

 

 

 

Class A Non-Voting Common Stock, par value $0.01 per share; shares authorized: 100 million; issued and outstanding: 52,332,848 as of September 30, 2020 and 52,565,064 as of September 30, 2019

521

 

 

526

 

Class B Voting Common Stock, convertible, par value $0.01 per share; shares authorized: 3 million; issued and outstanding: 2,970,171 as of September 30, 2020 and 2019

30

 

 

30

 

Additional paid-in capital

398,475

 

 

407,628

 

Retained earnings

318,169

 

 

389,163

 

Accumulated other comprehensive loss

(68,068

)

 

(52,398

)

Total equity

649,127

 

 

744,949

 

Total liabilities and equity

$

1,197,023

 

 

$

1,083,702

 

 

EZCORP, Inc.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

 

Fiscal Year Ended September 30,

 

2020

 

2019

 

2018

 

(in thousands)

Operating activities:

 

 

 

 

 

Net (loss) income

$

(68,463

)

 

$

1,311

 

 

$

36,294

 

Adjustments to reconcile net (loss) income to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

30,827

 

 

28,797

 

 

25,484

 

Amortization of debt discount and deferred financing costs

13,200

 

 

19,759

 

 

17,595

 

Amortization of lease right-of-use asset

45,649

 

 

 

 

 

Accretion of notes receivable discount and deferred compensation fee

(821

)

 

(4,524

)

 

(9,150

)

Deferred income taxes

(8,393

)

 

1,616

 

 

7,916

 

Impairment of goodwill, intangibles and other assets

54,666

 

 

 

 

 

Other adjustments

1,652

 

 

5,776

 

 

2,607

 

Reserve on jewelry scrap receivable

 

 

3,646

 

 

 

Stock compensation expense

(5,094

)

 

9,751

 

 

10,784

 

Equity in net loss (gain) from investment in unconsolidated affiliates

2,429

 

 

135

 

 

(5,529

)

Impairment of investment in unconsolidated affiliates

 

 

19,725

 

 

11,712

 

Changes in operating assets and liabilities, net of business acquisitions:

 

 

 

 

 

Pawn service charges receivable

11,021

 

 

(732

)

 

(1,788

)

Inventory

17,043

 

 

(493

)

 

(1,074

)

Prepaid expenses, other current assets and other assets

(875

)

 

5,732

 

 

477

 

Accounts payable, accrued expenses and other liabilities

(37,401

)

 

22,246

 

 

(3,271

)

Customer layaway deposits

(1,647

)

 

1,176

 

 

709

 

Income taxes, net of excess tax benefit from stock compensation

(4,715

)

 

(10,404

)

 

(3,785

)

Net cash provided by operating activities

49,078

 

 

103,517

 

 

88,981

 

Investing activities:

 

 

 

 

 

Loans made

(568,368

)

 

(737,585

)

 

(707,220

)

Loans repaid

394,469

 

 

434,142

 

 

421,331

 

Recovery of pawn loan principal through sale of forfeited collateral

304,323

 

 

288,502

 

 

266,962

 

Capital expenditures, net

(28,526

)

 

(38,839

)

 

(40,474

)

Acquisitions, net of cash acquired

 

 

(8,116

)

 

(93,165

)

Investment in unconsolidated affiliate

 

 

 

 

(14,036

)

Principal collections on notes receivable

8,000

 

 

34,067

 

 

32,396

 

Net cash provided by (used in) investing activities

109,898

 

 

(27,829

)

 

(134,206

)

Financing activities:

 

 

 

 

 

Taxes paid related to net share settlement of equity awards

(1,459

)

 

(3,288

)

 

(311

)

Payout of deferred consideration

(350

)

 

 

 

 

Proceeds from borrowings, net of issuance costs

912

 

 

1,064

 

 

171,409

 

Payments on borrowings

(198

)

 

(196,093

)

 

(3,510

)

Repurchase of common stock

(5,158

)

 

 

 

 

Net cash (used in) provided by financing activities

(6,253

)

 

(198,317

)

 

167,588

 

Effect of exchange rate changes on cash and cash equivalents and restricted cash

(2,612

)

 

(507

)

 

(654

)

Net increase (decrease) in cash and cash equivalents and restricted cash

150,111

 

 

(123,136

)

 

121,709

 

Cash and cash equivalents and restricted cash at beginning of period

162,442

 

 

285,578

 

 

163,869

 

Cash and cash equivalents and restricted cash at end of period

$

312,553

 

 

$

162,442

 

 

$

285,578

 

Supplemental disclosure of cash flow information

 

 

 

 

 

Cash and cash equivalents

$

304,542

 

 

$

157,567

 

 

$

285,311

 

Restricted cash

8,011

 

 

4,875

 

 

267

 

Total cash and cash equivalents and restricted cash

$

312,553

 

 

$

162,442

 

 

$

285,578

 

Cash paid during the period for interest

$

8,489

 

 

$

12,900

 

 

$

8,412

 

Cash paid during the period for income taxes, net

$

9,753

 

 

$

11,132

 

 

$

13,676

 

 

 

 

 

 

 

Non-cash investing and financing activities:

 

 

 

 

 

Pawn loans forfeited and transferred to inventory

$

241,252

 

 

$

301,357

 

 

$

274,590

 

 

EZCORP, Inc.

OPERATING SEGMENT RESULTS

(Unaudited and in thousands)

 

 

Three Months Ended September 30, 2020

 

U.S. Pawn

 

Latin America Pawn

 

Lana

 

Other International

 

Total Segments

 

Corporate Items

 

Consolidated

 

 

(in thousands)

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

Merchandise sales

$

77,862

 

$

27,256

 

 

$

 

 

$

 

 

$

105,118

 

 

$

 

 

$

105,118

 

Jewelry scrapping sales

3,786

 

 

2,458

 

 

 

 

 

 

6,244

 

 

 

 

6,244

 

Pawn service charges

43,222

 

 

12,009

 

 

 

 

 

 

55,231

 

 

 

 

55,231

 

Other revenues

43

 

 

(50

)

 

21

 

 

253

 

 

267

 

 

 

 

267

 

Total revenues

124,913

 

 

41,673

 

 

21

 

 

253

 

 

166,860

 

 

 

 

166,860

 

Merchandise cost of goods sold

49,056

 

 

23,714

 

 

 

 

 

 

72,770

 

 

 

 

72,770

 

Jewelry scrapping cost of goods sold

2,634

 

 

1,878

 

 

 

 

 

 

4,512

 

 

 

 

4,512

 

Other cost of revenues

 

 

32

 

 

 

 

(71

)

 

(39

)

 

 

 

(39

)

Net revenues

73,223

 

 

16,049

 

 

21

 

 

324

 

 

89,617

 

 

 

 

89,617

 

Operating expenses (income):

 

 

 

 

 

 

 

 

 

 

 

 

 

Operations

59,687

 

 

16,423

 

 

699

 

 

1,396

 

 

78,205

 

 

 

 

78,205

 

Administrative

 

 

 

 

 

 

 

 

 

 

3,100

 

 

3,100

 

Impairment of goodwill, intangibles and other assets

 

 

2

 

 

 

 

25

 

 

27

 

 

7,579

 

 

7,606

 

Depreciation and amortization

2,705

 

 

1,839

 

 

332

 

 

8

 

 

4,884

 

 

2,769

 

 

7,653

 

Loss (gain) on sale or disposal of assets and other

151

 

 

 

 

 

 

 

 

151

 

 

(610

)

 

(459

)

Other Charges

3,106

 

 

1,715

 

 

3,258

 

 

3,802

 

 

11,881

 

 

8,507

 

 

20,388

 

Interest expense

 

 

255

 

 

 

 

85

 

 

340

 

 

5,543

 

 

5,883

 

Interest income

 

 

(425

)

 

 

 

 

 

(425

)

 

(336

)

 

(761

)

Equity in net loss of unconsolidated affiliates

 

 

 

 

 

 

(3,467

)

 

(3,467

)

 

 

 

(3,467

)

Other expense (income)

 

 

147

 

 

 

 

(8

)

 

139

 

 

59

 

 

198

 

Segment contribution (loss)

$

7,574

 

 

$

(3,907

)

 

$

(4,268

)

 

$

(1,517

)

 

$

(2,118

)

 

 

 

 

Income (loss) from continuing operations before income taxes

 

 

 

 

 

 

 

 

$

(2,118

)

 

$

(26,611

)

 

$

(28,729

)

 

Three Months Ended September 30, 2019

 

U.S. Pawn

 

Latin America Pawn

 

Lana

 

Other International

 

Total Segments

 

Corporate Items

 

Consolidated

 

 

(in thousands)

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

Merchandise sales

$

80,357

 

$

26,832

 

 

$

 

 

$

 

 

$

107,189

 

 

$

 

 

$

107,189

 

Jewelry scrapping sales

17,458

 

 

5,114

 

 

 

 

 

 

22,572

 

 

 

 

22,572

 

Pawn service charges

63,711

 

 

19,357

 

 

 

 

 

 

83,068

 

 

 

 

83,068

 

Other revenues

108

 

 

45

 

 

 

 

1,357

 

 

1,510

 

 

 

 

1,510

 

Total revenues

161,634

 

 

51,348

 

 

 

 

1,357

 

 

214,339

 

 

 

 

214,339

 

Merchandise cost of goods sold

52,205

 

 

20,120

 

 

 

 

 

 

72,325

 

 

 

 

72,325

 

Jewelry scrapping cost of goods sold

15,638

 

 

4,649

 

 

 

 

 

 

20,287

 

 

 

 

20,287

 

Other cost of revenues

 

 

 

 

 

 

871

 

 

871

 

 

 

 

871

 

Net revenues

93,791

 

 

26,579

 

 

 

 

486

 

 

120,856

 

 

 

 

120,856

 

Operating expenses (income):

 

 

 

 

 

 

 

 

 

 

 

 

 

Operations

68,119

 

 

19,496

 

 

2,694

 

 

1,207

 

 

91,516

 

 

 

 

91,516

 

Administrative

 

 

 

 

 

 

 

 

 

 

14,176

 

 

14,176

 

Depreciation and amortization

2,928

 

 

1,724

 

 

10

 

 

29

 

 

4,691

 

 

2,992

 

 

7,683

 

Loss (gain) on sale or disposal of assets

546

 

 

(52

)

 

 

 

260

 

 

754

 

 

2

 

 

756

 

Interest expense

 

 

39

 

 

 

 

211

 

 

250

 

 

5,175

 

 

5,425

 

Interest income

 

 

(375

)

 

 

 

 

 

(375

)

 

(1,074

)

 

(1,449

)

Equity in net income of unconsolidated affiliates

 

 

 

 

 

 

767

 

 

767

 

 

 

 

767

 

Other (income) expense

 

 

(30

)

 

 

 

1,605

 

 

1,575

 

 

(30

)

 

1,545

 

Segment contribution (loss)

$

22,198

 

 

$

5,777

 

 

$

(2,704

)

 

$

(3,593

)

 

$

21,678

 

 

 

 

 

Income from continuing operations before income taxes

 

 

 

 

 

 

 

 

$

21,678

 

 

$

(21,241

)

 

$

437

 

 

Fiscal Year Ended September 30, 2020

 

U.S. Pawn

 

Latin America Pawn

 

Lana

 

Other International

 

Total Segments

 

Corporate Items

 

Consolidated

 

 

(in thousands)

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

Merchandise sales

$

391,921

 

$

106,292

 

 

$

 

 

$

 

 

$

498,213

 

 

$

 

 

$

498,213

 

Jewelry scrapping sales

36,691

 

 

11,262

 

 

 

 

 

 

47,953

 

 

 

 

47,953

 

Pawn service charges

210,081

 

 

62,557

 

 

 

 

 

 

272,638

 

 

 

 

272,638

 

Other revenues

150

 

 

 

 

34

 

 

3,823

 

 

4,007

 

 

 

 

4,007

 

Total revenues

638,843

 

 

180,111

 

 

34

 

 

3,823

 

 

822,811

 

 

 

 

822,811

 

Merchandise cost of goods sold

251,544

 

 

82,937

 

 

 

 

 

 

334,481

 

 

 

 

334,481

 

Jewelry scrapping cost of goods sold

28,064

 

 

9,977

 

 

 

 

 

 

38,041

 

 

 

 

38,041

 

Other cost of revenues

 

 

101

 

 

 

 

953

 

 

1,054

 

 

 

 

1,054

 

Net revenues

359,235

 

 

87,096

 

 

34

 

 

2,870

 

 

449,235

 

 

 

 

449,235

 

Operating expenses (income):

 

 

 

 

 

 

 

 

 

 

 

 

 

Operations

261,608

 

 

69,916

 

 

4,270

 

 

5,246

 

 

341,040

 

 

 

 

341,040

 

Administrative

 

 

 

 

 

 

 

 

 

 

49,897

 

 

49,897

 

Impairment of goodwill, intangibles and other assets

10,000

 

 

35,938

 

 

 

 

1,149

 

 

47,087

 

 

7,579

 

 

54,666

 

Depreciation and amortization

11,030

 

 

7,315

 

 

1,058

 

 

68

 

 

19,471

 

 

11,356

 

 

30,827

 

Loss (gain) on sale or disposal of assets and other

385

 

 

(72

)

 

 

 

(20

)

 

293

 

 

508

 

 

801

 

Other Charges

3,106

 

 

1,715

 

 

3,258

 

 

3,802

 

 

11,881

 

 

8,507

 

 

20,388

 

Interest expense

 

 

685

 

 

 

 

549

 

 

1,234

 

 

21,238

 

 

22,472

 

Interest income

 

 

(1,586

)

 

 

 

 

 

(1,586

)

 

(1,587

)

 

(3,173

)

Equity in net loss of unconsolidated affiliates

 

 

 

 

 

 

2,429

 

 

2,429

 

 

 

 

2,429

 

Other expense (income)

 

 

(156

)

 

 

 

6

 

 

(150

)

 

133

 

 

(17

)

Segment contribution (loss)

$

73,106

 

 

$

(26,659

)

 

$

(8,552

)

 

$

(10,359

)

 

$

27,536

 

 

 

 

 

Income from continuing operations before income taxes

 

 

 

 

 

 

 

 

$

27,536

 

 

$

(97,631

)

 

$

(70,095

)

 

Fiscal Year Ended September 30, 2019

 

U.S. Pawn

 

Latin America Pawn

 

Lana

 

Other International

 

Total Segments

 

Corporate Items

 

Consolidated

 

 

(in thousands)

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

Merchandise sales

$

355,996

 

$

97,379

 

 

$

 

 

$

 

 

$

453,375

 

 

$

 

 

$

453,375

 

Jewelry scrapping sales

45,815

 

 

14,630

 

 

 

 

 

 

60,445

 

 

 

 

60,445

 

Pawn service charges

248,369

 

 

78,997

 

 

 

 

 

 

327,366

 

 

 

 

327,366

 

Other revenues

233

 

 

179

 

 

 

 

5,631

 

 

6,043

 

 

 

 

6,043

 

Total revenues

650,413

 

 

191,185

 

 

 

 

5,631

 

 

847,229

 

 

 

 

847,229

 

Merchandise cost of goods sold

225,136

 

 

72,372

 

 

 

 

 

 

297,508

 

 

 

 

297,508

 

Jewelry scrapping cost of goods sold

39,318

 

 

13,617

 

 

 

 

 

 

52,935

 

 

 

 

52,935

 

Other cost of revenues

 

 

 

 

 

 

2,338

 

 

2,338

 

 

 

 

2,338

 

Net revenues

385,959

 

 

105,196

 

 

 

 

3,293

 

 

494,448

 

 

 

 

494,448

 

Operating expenses (income):

 

 

 

 

 

 

 

 

 

 

 

 

 

Operations

269,003

 

 

74,199

 

 

7,675

 

 

7,376

 

 

358,253

 

 

 

 

358,253

 

Administrative

 

 

 

 

 

 

 

 

 

 

55,990

 

 

55,990

 

Depreciation and amortization

11,879

 

 

6,267

 

 

10

 

 

219

 

 

18,375

 

 

10,422

 

 

28,797

 

Loss on sale or disposal of assets

3,402

 

 

691

 

 

 

 

282

 

 

4,375

 

 

24

 

 

4,399

 

Interest expense

 

 

1,609

 

 

 

 

491

 

 

2,100

 

 

30,537

 

 

32,637

 

Interest income

 

 

(1,601

)

 

 

 

 

 

(1,601

)

 

(9,485

)

 

(11,086

)

Equity in net income of unconsolidated affiliates

 

 

 

 

 

 

135

 

 

135

 

 

 

 

135

 

Impairment of investment in unconsolidated affiliates

 

 

 

 

 

 

19,725

 

 

19,725

 

 

 

 

19,725

 

Other income

 

 

(93

)

 

 

 

1,895

 

 

1,802

 

 

(378

)

 

1,424

 

Segment contribution (loss)

$

101,675

 

 

$

24,124

 

 

$

(7,685

)

 

$

(26,830

)

 

$

91,284

 

 

 

 

 

Income from continuing operations before income taxes

 

 

 

 

 

 

 

 

$

91,284

 

 

$

(87,110

)

 

$

4,174

 

 

EZCORP, Inc.

STORE COUNT ACTIVITY

(Unaudited)

 

Three Months Ended September 30, 2020

 

U.S. Pawn

 

Latin America Pawn

 

Other International

 

Consolidated

 

 

 

 

 

 

 

 

As of June 30, 2020

511

 

 

496

 

 

22

 

 

1,029

 

New locations opened

 

 

7

 

 

 

 

7

 

Locations acquired

 

 

 

 

 

 

 

Locations sold, combined or closed

(6

)

 

(3

)

 

(22

)

 

(31

)

As of September 30, 2020

505

 

 

500

 

 

 

 

1,005

 

 

 

Three Months Ended September 30, 2019

 

U.S. Pawn

 

Latin America Pawn

 

Other International

 

Consolidated

 

 

 

 

 

 

 

 

As of June 30, 2019

514

 

 

470

 

 

22

 

 

1,006

 

New locations opened

 

 

10

 

 

 

 

10

 

Locations acquired

 

 

 

 

 

 

 

Locations sold, combined or closed

(2

)

 

 

 

 

 

(2

)

As of September 30, 2019

512

 

 

480

 

 

22

 

 

1,014

 

 

 

Twelve Months Ended September 30, 2020

 

U.S. Pawn

 

Latin America Pawn

 

Other International

 

Consolidated

 

 

 

 

 

 

 

 

As of September 30, 2019

512

 

 

480

 

 

22

 

 

1,014

 

New locations opened

 

 

23

 

 

 

 

23

 

Locations acquired

 

 

 

 

 

 

 

Locations sold, combined or closed

(7

)

 

(3

)

 

(22

)

 

(32

)

As of September 30, 2020

505

 

 

500

 

 

 

 

1,005

 

 

 

Twelve Months Ended September 30, 2019

 

U.S. Pawn

 

Latin America Pawn

 

Other International

 

Consolidated

 

 

 

 

 

 

 

 

As of September 30, 2018

508

 

 

453

 

 

27

 

 

988

 

New locations opened

 

 

22

 

 

 

 

22

 

Locations acquired

7

 

 

5

 

 

 

 

12

 

Locations sold, combined or closed

(3

)

 

 

 

(5

)

 

(8

)

As of September 30, 2019

512

 

 

480

 

 

22

 

 

1,014

 

Non-GAAP Financial Information (Unaudited)

In addition to the financial information prepared in conformity with accounting principles generally accepted in the United States (“GAAP”), we provide certain other non-GAAP financial information on a constant currency (“constant currency”) and adjusted basis. We use constant currency results to evaluate our Latin America Pawn operations, which are denominated primarily in Mexican pesos and other Latin American currencies. We believe that presentation of constant currency and adjusted results is meaningful and useful in understanding the activities and business metrics of our operations and reflect an additional way of viewing aspects of our business that, when viewed with GAAP results, provide a more complete understanding of factors and trends affecting our business. We provide non-GAAP financial information for informational purposes and to enhance understanding of our GAAP consolidated financial statements. We use this non-GAAP financial information primarily to evaluate and compare operating results across accounting periods.

Readers should consider the information in addition to, but not instead of or superior to, our financial statements prepared in accordance with GAAP. This non-GAAP financial information may be determined or calculated differently by other companies, limiting the usefulness of those measures for comparative purposes.

Constant currency results reported herein are calculated by translating consolidated balance sheet and consolidated statement of operations items denominated in local currency to U.S. dollars using the exchange rate from the prior-year comparable period, as opposed to the current period, in order to exclude the effects of foreign currency rate fluctuations. We used the end-of-period rate for balance sheet items and the average closing daily exchange rate on a monthly basis during the appropriate period for statement of operations items. The end-of-period and approximate average exchange rates for each applicable currency as compared to U.S. dollars as of and for the three and twelve months ended September 30, 2020 and 2019 were as follows:

 

 

September 30,

 

Three Months Ended

September 30,

 

Twelve Months Ended

September 30,

 

 

2020

 

2019

 

2020

 

2019

 

2020

 

2019

 

 

 

 

 

 

 

 

 

 

 

 

 

Mexican peso

 

21.6

 

 

19.7

 

 

22.1

 

 

19.4

 

 

21.0

 

 

19.4

 

Guatemalan quetzal

 

7.6

 

 

7.6

 

 

7.5

 

 

7.5

 

 

7.5

 

 

7.6

 

Honduran lempira

 

24.3

 

 

24.2

 

 

24.3

 

 

24.1

 

 

24.3

 

 

24.1

 

Peruvian sol

 

3.5

 

 

3.4

 

 

3.5

 

 

3.3

 

 

3.4

 

 

3.3

 

Our statement of operations constant currency results reflect the monthly exchange rate fluctuations and so are not directly calculable from the above rates. Constant currency results, where presented, also exclude the foreign currency gain or loss.

Miscellaneous Non-GAAP Financial Measures

 

2020 Q4

 

2019 Q4

 

(in millions)

Net loss

$

(23.3

)

 

$

(0.6

)

Loss from discontinued operations, net of tax

 

 

0.1

 

Interest expense

5.9

 

 

5.4

 

Interest income

(0.8

)

 

(1.4

)

Income tax (benefit) expense

(5.4

)

 

1.0

 

Depreciation and amortization

7.7

 

 

7.7

 

Adjusted EBITDA

$

(16.0

)

 

$

12.1

 

 

 

Total Revenues

 

Net Revenues

 

(Loss) Income Before Tax

 

Tax Effect

 

Net (Loss) Income

 

Adjusted EBITDA

 

Diluted EPS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2020 Q4 Reported

$

166.9

 

$

89.6

 

$

(28.7

)

 

$

5.4

 

 

$

(23.3

)

 

$

(16.0

)

 

$

(0.42

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other charges

 

 

 

 

20.4

 

 

(3.7

)

 

16.7

 

 

20.4

 

 

0.30

 

Impairment of intangible assets

 

 

 

 

7.6

 

 

(1.7

)

 

5.9

 

 

7.6

 

 

0.11

 

Non cash interest

 

 

 

 

3.3

 

 

(0.8

)

 

2.5

 

 

 

 

0.05

 

Other adjustments

 

 

 

 

0.7

 

 

1.8

 

 

2.5

 

 

(0.2

)

 

0.04

 

Constant currency impact

4.0

 

 

1.7

 

 

(0.4

)

 

(0.1

)

 

(0.5

)

 

0.2

 

 

(0.01

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2020 Q4 Adjusted

$

170.9

 

 

$

91.3

 

 

$

2.9

 

 

$

0.9

 

 

$

3.8

 

 

$

12.0

 

 

$

0.07

 

 

 

Total Revenues

 

Net Revenues

 

(Loss) Income Before Tax

 

Tax Effect

 

Net (Loss) Income

 

Adjusted EBITDA

 

Diluted EPS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019 Q4 Reported

$

214.3

 

 

$

120.9

 

 

$

0.4

 

 

$

1.0

 

 

$

(0.6

)

 

$

12.1

 

 

$

(0.01

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other charges

 

 

 

 

2.4

 

 

0.4

 

 

2.0

 

 

 

 

0.04

 

Impairment of intangible assets

 

 

 

 

2.0

 

 

0.3

 

 

1.7

 

 

2.0

 

 

0.03

 

Non cash interest

 

 

 

 

1.9

 

 

0.3

 

 

1.6

 

 

1.9

 

 

0.03

 

Other adjustments

 

 

0.2

 

 

1.7

 

 

0.3

 

 

1.4

 

 

1.7

 

 

0.02

 

Constant currency impact

 

 

 

 

1.6

 

 

0.3

 

 

1.3

 

 

1.6

 

 

0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019 Q4 Adjusted*

$

214.3

 

$

121.1

 

$

10.0

 

$

2.6

 

$

7.4

 

 

$

19.3

 

$

0.13

 

* During the first quarter of fiscal 2020, we revised the financial information our chief operating decision maker (our chief executive officer) reviews for operational decision-making purposes to include the separate financial results of our Lana business. Our historical segment results have been recast to conform to current presentation including the removal of discretionary strategic investment in digital platform costs in historically adjusted results. We additionally recast certain other adjustments to conform to restated historical results.

2020 Q4:

U.S. Dollar Amount

 

Percentage Change YOY

 

(in millions)

 

 

Consolidated revenue (three months ended September 30, 2020)

$

166.9

 

 

(22)

%

Currency exchange rate fluctuations

4.0

 

 

 

Constant currency consolidated revenue (three months ended September 30, 2020)

$

170.9

 

 

(20)

%

 

 

 

 

Consolidated net revenue (three months ended September 30, 2020)

$

89.6

 

 

(26)

%

Currency exchange rate fluctuations

$

1.7

 

 

 

Constant currency consolidated net revenue (three months ended September 30, 2020)

$

91.3

 

 

(24)

%

 

 

 

 

Consolidated net inventory

$

95.9

 

 

(47)

%

Currency exchange rate fluctuations

$

1.7

 

 

 

Constant currency consolidated net inventory

$

97.6

 

 

(46)

%

 

 

 

 

Latin America Pawn net revenue (three months ended September 30, 2020)

$

16.0

 

 

(40)

%

Currency exchange rate fluctuations

$

1.7

 

 

 

Constant currency Latin America Pawn net revenue (three months ended September 30, 2020)

$

17.8

 

 

(33)

%

 

 

 

 

Latin America Pawn PLO

$

25.0

 

 

(40)

%

Currency exchange rate fluctuations

$

2.4

 

 

 

Constant currency Latin America Pawn PLO

$

27.4

 

 

(34)

%

 

 

 

 

Latin America Pawn PSC revenues (three months ended September 30, 2020)

$

12.0

 

 

(38)

%

Currency exchange rate fluctuations

$

1.1

 

 

 

Constant currency Latin America Pawn PSC revenues (three months ended September 30, 2020)

$

13.1

 

 

(32)

%

 

 

 

 

Latin America Pawn merchandise sales (three months ended September 30, 2020)

$

27.3

 

 

2

%

Currency exchange rate fluctuations

$

2.8

 

 

 

Constant currency Latin America Pawn merchandise sales (three months ended September 30, 2020)

$

30.0

 

 

12

%

 

 

 

 

Latin America Pawn segment profit before tax (three months ended September 30, 2020)

$

(3.9)

 

 

(168)

%

Currency exchange rate fluctuations

$

(0.3)

 

 

 

Constant currency Latin America Pawn segment profit before tax (three months ended September 30, 2020)

$

(4.2)

 

 

(103)

%

 

Email: [email protected]

Phone: (512) 314-2220

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Professional Services Retail Discount/Variety Specialty Finance Banking

MEDIA: